back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-18 15:27 Tx date 2025-06-05 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
36 - Conversion or exchange
|
+51,417 vol |
51,417 | |
| Filed 2025-06-18 15:26 Tx date 2025-06-05 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
36 - Conversion or exchange
|
-$330,000 vol |
$0 | |
| Filed 2025-06-18 15:25 Tx date 2025-06-05 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
36 - Conversion or exchange
|
-$330,000 vol |
||
| Filed 2025-06-18 15:23 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Subordinate Voting Shares Class B
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-18 15:23 Tx date 2025-06-05 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
36 - Conversion or exchange
|
-$330,000 vol |
||
| Filed 2025-06-18 15:09 Tx date 2025-03-28 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+25,080 vol |
25,080 | |
| Filed 2025-06-18 15:05 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-18 15:05 Tx date 2025-03-28 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
+$330,000 vol |
$330,000 | |
| Filed 2025-06-18 15:02 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-18 15:01 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-18 14:55 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$330,000 | ||
| Filed 2025-06-18 14:55 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Holder: CBKT Ventures Inc. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-18 14:48 Tx date 2025-03-26 |
$QNTM
Quantum BioPharma Ltd. |
Lynch, Terry
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2025-06-14 13:02 Tx date 2024-08-23 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-35,000 vol |
0 | |
| Filed 2025-06-14 12:59 Tx date 2024-08-15 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-2,462 vol |
38 | |
| Filed 2025-06-13 18:03 Tx date 2025-06-03 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-60,480
-3,000 vol $20.16 each |
2,500 | |
| Filed 2025-06-13 18:00 Tx date 2025-06-02 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$15,750
+3,000 vol $5.25 each |
5,500 | |
| Filed 2025-06-13 17:57 Tx date 2025-06-02 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,750
-3,000 vol $5.25 each |
35,000 | |
| Filed 2025-04-07 15:43 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
105,414 | |
| Filed 2025-04-07 15:42 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-04-07 15:40 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
15,628 | |
| Filed 2025-04-07 15:40 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-04-07 15:39 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-04-07 15:38 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
118,107 | |
| Filed 2025-04-07 15:37 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-07 15:37 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-07 15:24 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
90,412 | |
| Filed 2025-04-07 15:23 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-04-03 15:18 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:17 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
$88,458
+7,692 vol $11.50 each |
||
| Filed 2025-04-03 15:16 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:14 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:13 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:13 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:10 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:09 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
58 - Expiration of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:18 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
0 | |
| Filed 2025-04-03 15:17 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
$88,458
+7,692 vol $11.50 each |
90,412 | |
| Filed 2025-04-03 15:16 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:14 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:13 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:13 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-7,692 vol |
||
| Filed 2025-04-03 15:10 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
57 - Exercise of rights
|
+7,692 vol |
||
| Filed 2025-04-03 15:09 Tx date 2025-04-03 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
58 - Expiration of rights
|
-7,692 vol |
||
| Filed 2025-03-11 17:55 Tx date 2024-08-15 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-492,308 vol |
7,692 | |
| Filed 2025-03-11 17:41 Tx date 2025-03-07 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,767
+7,692 vol $6.60 each |
7,692 | |
| Filed 2025-03-11 17:38 Tx date 2025-03-07 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,767
+7,692 vol $6.60 each |
||
| Filed 2025-03-10 17:11 Tx date 2025-03-07 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,767
+7,692 vol $6.60 each |
||
| Filed 2025-03-10 17:22 Tx date 2025-02-26 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Warrants
97 - Other
|
-7,692 vol |
492,308 | |
| Filed 2025-03-10 17:11 Tx date 2025-03-07 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,767
+7,692 vol $6.60 each |
7,692 | |
| Filed 2025-03-10 17:09 Tx date 2023-06-29 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-02-07 16:51 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-109,515
-4,900 vol $22.35 each |
436 | |
| Filed 2025-02-07 16:51 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-59,098
-2,600 vol $22.73 each |
5,336 | |
| Filed 2025-02-07 16:50 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$39,375
+7,500 vol $5.25 each |
7,936 | |
| Filed 2025-02-07 16:50 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,375
-7,500 vol $5.25 each |
0 | |
| Filed 2025-02-07 16:49 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,375
-7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:49 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:49 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-59,098
-2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:49 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$39,375
+7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:48 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:47 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
40 - Short sale
|
$-59,098
-2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:39 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$39,375
+7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:38 Tx date 2025-02-07 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,375
-7,500 vol $5.25 each |
||
| Filed 2025-02-07 16:37 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-59,098
-2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:37 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-109,515
-4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:36 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:36 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$59,098
+2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:11 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$109,515
+4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:11 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-109,515
-4,900 vol $22.35 each |
||
| Filed 2025-02-07 16:10 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subordinate Voting Shares Class B
51 - Exercise of options
|
$59,098
+2,600 vol $22.73 each |
||
| Filed 2025-02-07 16:09 Tx date 2025-02-06 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-59,098
-2,600 vol $22.73 each |